Trump administration demands pharma companies begin drug price negotiations, a day after key deadline The administration plans to set up a system for patients to buy drugs directly from pharma companies at lower prices

https://www.statnews.com/2025/06/12/trump-administration-demands-drug-companies-start-negotiating-prices/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_5bTUebsKIXiaMbKCcyQhricXo7UEJZpd_noVEQkO0P6mobVDbcWXpqER5EysVHNVLZVPf7v9z-gU7uYryfN73UsjIpQ&_hsmi=366507755&utm_content=366507755&utm_source=hs_email Trump to pharma: lower drug prices *now* The Trump administration is pushing pharmaceutical companies to voluntarily lower drug prices and allow companies to sell their drugs to Americans directly, but executives and industry lobbyists are antsy about taking the next step. Lower priced drugs were a key part of Trump’s presidential agenda, that Americans would pay no more than the lowest price for drugs paid by peer nations, but the administration’s demands have been short on details since announcing the policy in May. The administration has not yet detailed how it would establish a direct-to-consumer mechanism, though it says that it has given companies price targets for their drugs: the lowest price offered in peer nations. It’s the latest update in a weekslong saga that does not show any sign of ending soon. Will pharma companies voluntarily bend under the administration’s scrutiny? Read more from STAT’s Daniel Payne to find out. https://www.statnews.com/2025/06/12/trump-administration-demands-drug-companies-start-negotiating-prices/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-8ddOiYnLUD2e9YfCehXzd3Nt0XGFkWG1iYtQ-yqiPVZesIG7QiC3DAZyux_ehfOBM0Xi0jR4qir5khwtZzL3fVve2u-g&_hsmi=366507755&utm_content=366507755&utm_source=hs_email